Advertisement
FDA Alerts
FDA Alerts
04/03/2023

Jessica Ganga

Jessica Ganga
The FDA approves the overdose medication for over-the-counter use after data supports its safe use.
04/03/2023
Research Summary
Research Summary
01/23/2023
Researchers examined the implementation of a restricted opioid prescribing plan for patients who experienced pain post-surgery in efforts to reduce chronic opioid use.
01/23/2023
Pain Medicine
Pain Medicine
11/07/2022
Researchers find that presurgical cannabis use may increase patients’ postsurgical pain when compared to surgical patients who do not use cannabis. The research was presented at the Anesthesiology 2022...
11/07/2022
mortality
mortality
06/29/2022
To better understand mortality trends within the United States, researchers examined the rate of death in people who died of alcohol-related liver disease.
06/29/2022
Cannabis Use
Cannabis Use
06/15/2022
The researchers assessed how the legalization of nonmedical cannabis affected the use of alcohol, cigarettes, and pain medication use in Washington state.
06/15/2022
opioids
opioids
11/09/2020
In a recent study, researchers sought to better establish the prescribing practices of gynecology residents to manage post-operative pain.
11/09/2020
Opioid addiction
Opioid addiction
05/15/2019
In a recent study, researchers used data from insurance claims to examine trends in post-surgery opioid prescribing and the likelihood of prolonged use with various opioids.
05/15/2019
Opioid addiction
Opioid addiction
01/09/2019
Use of tobacco and the co-prescription of sedative hypnotics have been shown to be risk factors for the misuse of prescribed opioids, but the association between these drugs has not yet been clarified. ...
01/09/2019
Opioid addiction
Opioid addiction
12/20/2018
The US Department of Health and Human Services has released a new set of recommendations for the coprescription of naloxone in patients at high-risk for opioid overdose.
12/20/2018
Opioid addiction
Opioid addiction
05/16/2018
In a new study, researchers investigated whether weekly and monthly subcutaneous buprenorphine depot formulations were noninferior to a daily sublingual combination of buprenorphine and naloxone for the...
05/16/2018